Credit: Getty Images. The combination antibiotic consists of aztreonam, a monobactam β-lactam and avibactam, a broad-spectrum β-lactamase inhibitor. The investigational antibiotic combination ...

The Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation and Fast Track designation to ATM-AVI (aztreonam and avibactam; Allergan) for the treatment ...

Please provide your email address to receive an email when new articles are posted on . Aztreonam-avibactam was well tolerated and comparable in efficacy to meropenem. Pfizer plans to start the ...

Review the side-effects of Aztreonam as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis Data Presented at Cystic Fibrosis Therapeutics Development Network ...

Aztreonam (Azvzn (1000 mg) is monobactam antibiotic, prescribed for serious infections caused by susceptible gram negative bacteria like urinary tract infection, lower respiratory tract infection. It ...

Patients with CF often require long-term antibiotic therapy for recurrent lung infections, which may increase the likelihood of antimicrobial resistance. To date, no clinical trial has specifically ...

Gilead Sciences has moved a step closer to getting approval for its cystic fibrosis treatment in the USA. Gilead Sciences has moved a step closer to getting approval for its cystic fibrosis treatment ...

Please provide your email address to receive an email when new articles are posted on . A clinical decision support tool advocating penicillin allergy testing in patients taking aztreonam has the ...

Am J Health Syst Pharm. 2012;69(2):107-115. In clinical trials, insufficient numbers of patients 65 years of age or older were included. Thus, responses among this population have not been firmly ...